等待开盘 01-17 09:30:00 美东时间
+0.900
+0.25%
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
Bernstein analyst Lee Hambright maintains Stryker (NYSE:SYK) with a Outperform and raises the price target from $450 to $465.
01-10 03:20
华尔街最受关注、且足以影响市场走势的分析师研报观点,现已汇总呈现。以下为《The Fly》整理的、投资者需重点关注的当日最新研报动态。 五大评级上调个股 ...
01-07 00:39
Medical technology is experiencing a paradigm shift as artificial intelligence ...
01-01 00:13
Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 1.46% ...
2025-12-29 22:21
今日重点评级关注:HC Wainwright & Co.:维持Pyxis Oncology"买入"评级,目标价从5美元升至7美元;Stifel:维持Oculis Holding"买入"评级,目标价从35美元升至40美元
2025-12-22 15:05
Citizens analyst David Turkaly upgrades Stryker (NYSE:SYK) from Market Perform to Market Outperform and announces $440 price target.
2025-12-19 21:36
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
2025-12-19 10:15
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
2025-12-12 10:24
Citigroup analyst Joanne Wuensch maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $455 to $420.
2025-12-12 05:06